Nuclear Medicine and Biology

Papers
(The TQCC of Nuclear Medicine and Biology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Reduction of the hepatic radioactivity levels of [111In]In-DOTA–labeled antibodies via cleavage of a linkage metabolized in lysosomes40
Radiosynthesis of Primary Amides Through 11C-Carbonylation by [11C]Carbon Monoxide Using GE FX Synthesis Modules39
Editorial Board31
Radiolabeling yield dependency of post-dry distillation decay of astatine-21130
Automated One-pot and One-step Radiosynthesis of [18F]VAT for PET Imaging of Vesicular Acetylcholine Transporter25
Preclinical Evaluation of [18F]F-[natLu]Lu-DOTA-rhCCK-18, the First 18F-Labeled Radiohybrid-Based Minigastrin Derivative with high Target Affinity and Tumor Accumulation24
Retraction notice to “Radiosynthesis and biological evaluation of fluorine-18 labeled N-acetylgalactosamine derivative [18F]FPGalNAc for PET imaging of asialoglycoprotein receptor-positive tumors”. [N23
177Lu and 227Th Labeled 3,4,3-(LI-1,2-HOPO): characterization, optimized synthesis, biological distribution and dosimetry20
Development of a novel Azabenzimidazoles-Based PET radioligands for γ-8 dependent transmembrane AMPA receptor regulatory protein imaging18
Simple method for the production of [11C]phosgene18
Longitudinal florzolotau (18F) PET study in a rat model of Alzheimer’s disease.18
N-(4-[18F]fluorobenzyl)cholylglycine, a potential tracer for positron emission tomography of enterohepatic circulation and drug-induced inhibition of ileal bile acid transport. A proof-of-concept PET/17
Synthesis of [11C]Me-DPA and evaluation in transgenic mouse model of Alzheimer’s disease17
PEGylated liposome encapsulating nido-carborane: boron neutron capture therapy (BNCT) and in vivo trafficking study in animal models17
Radiofluorination of Sterically Hindered Amides: Automation, Stability Studies, and Mechanism17
Synthesis of a porphyrin-PSMA conjugate and preliminary labelling with copper-6416
Indigenous preparation, quality control and evaluation of [90Y] Y-glass microspheres for treatment of liver cancer in India16
Improving PET imaging of urothelial carcinoma using manual synthesis of [68Ga]Ga-FAPI-46 and automated synthesis of [18F]AlF-FAPI-7415
Versatile diphosphine platforms for molecular radio-pharmaceuticals based on technetium-99m and rhenium-18815
[11C]HSP990 PET as a translational tool to investigate the aberrant role of Hsp90 in tumors and support the development of Hsp90 therapeutics15
Preclinical evaluation of [155/161Tb]Tb-crown-TATE – a novel SPECT imaging agent targeting neuroendocrine tumors14
Copper-mediated 18F-fluorination of boroxines: a systematic optimization study13
Chelator-based non-peptidic radiotracers for PET imaging of PD-L1 with copper-6413
Status of radiobiology in molecular radionuclide therapy – Hope for the future13
Perspectives on nuclear chemistry, radiochemistry, PET/SPECT imaging and radiotherapy12
An orthogonal labeling strategy to accelerate bioconjugation of [99mTc]Tc-building blocks12
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information11
Radiation dosimetry and efficacy of an 89Zr/225Ac-labeled humanized anti-MUC5AC antibody11
Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen11
A new, optimised diphosphine chemical platform for kit-based, receptor-targeted 99mTc and 188Re radiopharmaceuticals10
18F-labelling of T cells for in vivo evaluation of CAR T cell therapy10
Optimization and Routine Production of Gallium-68-Radiolabeled Agents Using a Cyclotron Liquid Target System and Automated Radiosynthesis10
Electroamalgamation-and Chromatography-Based Eu/Tb Separation Procedures as a Proof of Concept for Separating 155Tb from Alpha-Irradiated 153Eu10
Protocol for Automated Production of Radiofluorinated Boramino Acids10
Development of an Automated [18F]FBPA Synthesis Using a Commercially Available Precursor10
Impact of Different 177Lu Sources and Precursor Variations on the Quality of 177Lu-Labeled Theranostics10
Preclinical and Initial Clinical Evaluation of 68Ga/177Lu-Labeled Heterodimer Agents Targeting both Somatostatin Receptor and Integrin αVβ39
Radiosynthesis and first in vitro evaluation of [11C]Onalespib for Hsp90 cancer imaging9
Evaluation of Antibody-Based TREM2 PET in Mice: Contrasting Image-Derived Blood Normalization with the Standard %ID Normalization Method9
[68Ga]Ga-DOTA-C-glycosyl-RGD: synthesis, in vitro evaluation and PET imaging9
A fully automated synthesis of [18F]Fluro-L-meta-tyrosine (FMT) on AllInOne synthesizer9
Medical Radionuclide Production Using Nuclear Fusion9
[18F]FMISO-PET imaging reveals the role of hypoxia severity in checkpoint blockade response9
ATP Synthase is a Promising Target for Non-Invasive Imaging of Activated and Non-activated Adipose Tissues9
Enhancing Tumor Uptake Efficiency of Radioimmunoconjugates through DLS-Based Aggregation Detection and Removal9
Domestic Production of Therapeutic Isotopes Via Fusion9
Combining High-Throughput Radiochemical Experimentation Techniques with “Design of Experiments” (DoE) to Accelerate the Radiosynthesis Optimization of Novel Radiopharmaceuticals9
177LuIII- and 225AcIII-labelled bispidine-TATE conjugates: promising candidates for targeting neuroendocrine tumours8
What a difference an additional methylene makes: replacing Glu with Aad in the Lys-urea-Glu pharmacophore to reduce kidney and salivary gland uptake of PSMA-targeting radiopharmaceuticals8
Site-selective 18F-labelling of octreotide via disulfide rebridging8
Characterization of a PET radioligand suitable for imaging and quantification of sigma-2 receptor in the primate brain7
Mitochondria-targeted radiocomplexes for cancer theranostics7
89Zr-immuno-PET guided preclinical development of targeted therapies: demonstrating utility by evaluating fusion proteins in vivo7
Evaluation of Affibody molecule Z09591 for PET imaging in fibrosis7
The theranostic Goldilocks radionuclide copper-67 produced at a biomedical cyclotron7
Rhenium and technetium complexes in extremely low oxidation states7
Non-invasive imaging of neutrophils in acute sepsis7
Exploring the potential of high-specific activity samarium-153 for targeted radionuclide therapy with [153Sm]Sm-DOTA-TATE7
Targeting brain tumours with radiolabelled chlorotoxin, a scorpion venom peptide6
Next generation copper complexes for efficient production of radiolabeled aromatics6
Translation of [68Ga]Ga-PSMA-11 radiosynthesis on the microfluidic system iMiDEVTM6
[11C]Vercirnon - a candidate PET radioligand for the CCR9 chemokine receptor6
Introduction of terbium-161 into the clinics through its automated purification and the Good Manufacturing Practice compliant production of [161Tb]Tb-DOTA-LM36
Editorial Board6
Preclinical evaluation of [68Ga]Ga-BCY18469, a first-in-class EphA2-targeting radiotheranostic Bicyclic Peptide6
Development and radiolabelling of fluorinated ligands targetting the Aryl hydrocarbon Receptor6
Development and evaluation of new small molecule PET-radiotracers for the molecular imaging of inflammatory processes targeting S100A96
Development of Electrolytic Labeling of 211At to Iodotyrosine Derivatives5
Study of activation cross sections of double neutron capture reaction on 193Ir for the reactor production route of radiotherapeutic 195mPt5
Imaging Glucose Metabolism and Dopaminergic Dysfunction in Sheep (Ovis aries) Brain Using Positron Emission Tomography Imaging Reveals Abnormalities in OVT73 Huntington’s Disease Sheep5
[89Zr]ZrTrastuzumab automatic preparation on commercial cassette base synthesis module5
An efficient, versatile procedure for the [18F]-radiofluorination of base-sensitive tracers with high radiochemical conversion5
Non-Canonical Amino Acids Substitutions Modulate Biodistribution and Tumor Accumulation of FAP-Targeted Cyclic-peptide Radiotracers5
The development of [18F]-LQ-1-41 as a PET tracer for imaging KRAS G12D tumors5
Enhancing the accumulation level of 3-[18F]fluoro-L-α-methyltyrosine in tumors by preloading probenecid5
Design and Preclinical Evaluation of 68Ga-Labeled Covalently Modified Nectin-4 Targeting Peptide as a Potential Tumor Radiotracer5
Evaluation of [18F]TzPheBF3 cell uptake and intracellular iEDDA reactivity through in vitro studies using Hoechst-TCO5
A novel bispecific antibody for the enhanced delivery of radiopharmaceuticals to brain tumours5
Development of novel 18F-PET imaging probes for mTOR signaling in Focal cortical Dysplasia type II4
New prospects for 89Zr-immuno-PET in brain applications – Alpha-synucleinopathies4
Expression of concern “cross sections of the 226Ra(p,xn) reactions relevant for 225Ac production“4
Editorial Board4
Validation of an HPLC method for assessing the chemical and radiochemical purity of [18F]Sodium Fluoride radiopharmaceutical4
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information4
Surface Marker Diversity on Circulating Tumor Cells in Advanced Prostate Cancer Patients4
Girentuximab (TLX250) as a theranostic tool in triple-negative breast cancer treatment4
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information4
Fully automated and optimized [68Ga]Ga-NODAGA-Exendin-4 radiolabelling process on the TRASIS miniAllinOne4
GTP1 metabolic stability assessment: A study of the tau PET tracer [18F]GTP14
Development of an HCAR1 radiotracer4
Preclinical evaluation of MC1R targeting theranostic pair [155Tb]Tb-crown-αMSH and [161Tb]Tb-crown-αMSH4
18F-MGX-110S detects proinflammatory innate immune responses in human cells and Alzheimer’s disease mice with high sensitivity4
Synthesis and preclinical evaluation of [18F]AlF-NODA-MP-C6-CTHRSSVVC as a PET tracer for CD163-positive tumor-infiltrating macrophages4
Abstract withdrawn.3
Access to 18F-labeled FAP inhibitor variants via [18F]SuFEx reaction3
Isotopic fluorine-18 radiolabelling of the anti-retroviral drug dolutegravir for pet imaging3
Brain energetics by biomedical modalities3
Preclinical evaluation of [111In]In-labeled GRPR-targeting DB15 mimics for potential theranostic use in prostate cancer3
Clinical grade [15O]O2 Production for Human Inhalation PET/MRI study3
Developing a Novel Microfluidics-based 86Y Purification Strategy for Rapid and Efficient Radiopharmaceutical Production3
[55Co]Co-DOTA-SP4: Towards NK1R-targeted Theranostics of Glioblastoma3
Title Page3
Preparation and multimodality imaging study of 64Cu labeled organic nanoparticles targeting fibroblasts activation protein (FAP) in U87MG model3
Current developments in the production of actinium-225 from thorium-2293
Folate receptor targeted 64Cu/ICG-labeled layered double hydroxide nanoprobe for PET/CT and NIRF imaging3
Inorganic ion molar absorptivity at higher energy UV wavelengths and how it affects high performance liquid chromatography results3
Identifying Lymph Node Metastasis in High Grade Serous Ovarian Cancer Mouse Models via ImmunoPET Imaging3
Editorial Board3
Synthesis and biological evaluation of a novel radioligand [11C] BIO-1790735 for detection of O-GlcNAcase (OGA) enzyme activity3
Biodistribution of [18F]BCPP-BF in humans: a first-in-human positron emission tomography study3
Automated 18F-Al-radiolabelling optimization of PSMA-11 for PET imaging using a design of experiments approach3
Solid polyamine adsorbents for [11C]CO2 capture, purification, and radiosynthesis3
Synthesis of novel PSMA ligands and preclinical evaluation of [99mTc]TcO-ABX474, a radioligand for SPECT imaging of prostate cancer3
Automation of two-step one-vessel ditosylate synthon fluorination using Trasis AllinOne3
Automated Purification of 64Cu with the GE FastLab For GMP Production2
Development of small molecule PET-tracers targeting PD-L12
Comparative radiobiology of human leukemia cells and opportunistic fungal cells post treatment with 225Ac- and 177Lu-radiolabeled antibodies2
Radioactive Isotopes for Cancer Radiotherapy2
Synthesis of Bifunctional Macrocyclic Chelator2
Efficient chelation of 134Ce/La using the macrocyclic chelators DOTA and Macropa as potential PET imaging agents2
Trithiol ligand provides tumor-targeting 191Pt-complexes with high molar activity and promising in vivo properties2
Synthesis/radiosynthesis and evaluation of three 18F radiotracers for imaging of sphingosine-1-phosphate receptor 12
Evaluation of chelating agents based on pyridine-azacrown compounds H4PATA, PATAM, and H4PATPA for 68Ga and 177Lu2
Low-dose targeted alpha therapy induces strong anti-tumor effectiveness in combination with immune checkpoint inhibitors2
Studies of [89Zr]ZrDFO*-Labeled Human Serum Albumin Applying Different Cysteine Bioconjugation Chemistry2
A fluorescent probe as a lead compound for a selective α-synuclein PET tracer: development of a library of 2-styrylbenzothiazoles and biological evaluation of [18F]PFSB and [18F]MFSB2
Development of a PSMA Heterogeneous Tumor Model for Targeted Radiotherapy2
89Zr-radiolabeling of p-NCS-Bz-DFO-anti-HER2 affibody immunoconjugate and in vitro assessment of its potential in HER2+ breast cancer imaging2
Recovery and purification of Zn-68 after cyclotron irradiation and Ga-68 recovery2
Radiolabeling of a polypeptide polymer for intratumoral delivery of alpha-particle emitter, 225Ac, and beta-particle emitter, 177Lu2
In vitro study of 177Lu-DOTA-Trastuzumab and 177Lu-DOTA-Pertuzumab for evaluation of binding affinity towards human cell lines with differential expression of HER-2 receptor2
Cancer stem cell targeted short peptide for PET imaging using Cu-64 in breast cancer cell xenografted model2
Synthesis of a new 6-substituted 4-anilinoquinazoline derivative as irreversible inhibitor for EGFR imaging2
Comparison of biodistribution according to administration route for the development of liposome therapeutics2
A decade of ubiquicidin development for PET imaging of infection: A systematic review2
Radiosynthesis and evaluation of a new PET tracer for imaging of leucine-rich repeat kinase 22
Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffold2
The importance of radiochemical purity: Cellular binding and internalization of different radiometal chlorides in prostate cancer cells2
Ultra-fast and efficient conversion of [11C]CO2 into [11C]hydantoins via the Bucherer-Bergs multicomponent reaction2
225Aс/213Bi generator for direct synthesis of 213Bi-labeled bioconjugates2
Pretargeted PET imaging of trans-cyclooctene functionalized spherical nucleic acids2
Design of innovative FAP-target modules for simultaneous delivery of CAR-T cell-and radiotherapy2
Development of a highly hydrophilic 18F-tetrazine for pre-targeting approaches in PET imaging2
Targeted Alpha Therapy of Ovarian Cancer with ²¹²Pb-Labeled Anti-PTK7 Antibody: Efficient Production at Non-Clinical Scale and Preclinical Insights2
Radiobioconjugates of 193m,195mPt nanoparticles for combined “chemo-Auger electron” therapy of hepatocellular carcinoma (HCC) and HER2+ breast and ovarian cancers2
Demonstrating targeted delivery of an antisense oligonucleotide (ASO) to pancreatic insulin secreting-cells in non-human primates using positron emission tomography2
Corticolimbic activation patterns during aversive audiogenic stress assessed by cerebral perfusion using [99mTc]HMPAO SPECT/CT2
Recent advances in understanding and improving the stability of 211At-radiopharmaceuticals2
Novel Radiofluorinated Analogues of GSK321 for PET Imaging of mIDH1 in Gliomas2
Novel [124I]ATRi VE-821 analogue PET tracer in mouse models for prostate cancer2
Editorial Board2
Target occupancy studies of rho-associated protein kinase inhibitors in nonhuman primate with [11C]ROCK201 PET2
Scale up production and purification of high specific activity lead-203 (203Pb)2
Synthesis and evaluation of novel PET ligands for imaging Orexin2 receptor (OX2R)2
Radio-HPLC for 225Ac-Radiopharmaceuticals: Considerations on the Retrospective Reconstruction of the 225Ac-Specific Radio-Chromatogram by Three Different Methods2
Synthesis and preclinical evaluation of 99mTc sandwich complexes targeting LAT1 and CRBN2
CONTENTS1
In vitro and preliminary in vivo assessment of monocarboxylate transporter ligand as potential radiotracer for single photon emission computed tomography (SPECT) imaging of triple-negative breast canc1
Imaging resistance to anti-androgens in prostate cancer by multimodal 13C-pyruvate hyperpolarized magnetic resonance spectroscopy and 18F-pivalate positron emission tomography1
The development of terbium-155 and terbium-161 towards radiotheragnostic clinical applications1
development of novel fap inhibitors for cancer imaging and therapy: from rapid uptake to prolonged retention1
Quality assessment of cyclotron-produced 67Cu1
The development of a new type 103Pd/103mRh generator like cold brew coffee1
Development and validation of [18F]FDG dual radiosynthesis on a MX cassette with a NEPTIS® module1
Production of no-carrier-added holmium-166 by double neutron capture reaction at McMaster University research reactor1
Targetry of 152Tb PET radioisotope, member of theranostic isotopes of Terbium1
Albumin binders: a potential strategy for enhanced treatment of NETs using SSTR2 antagonists1
Evaluation of tetramethylammonium salts in minimalist-like SNAr radiofluorinations1
Correlation of hypoxia PET tracer uptake with hypoxic radioresistance in cancer cells: PET biomarkers of resistance to stereotactic radiation therapy?1
Evaluation of [11C]HSP990 as a PET probe for in vivo visualisation of heat shock protein 90 in tumours1
Promising potential 68Ga-labeled small-molecular tracers for immune checkpoint ligand PD-L1 expression in tumor1
The development of [11C]M503-1619 as a PET tracer for imaging α-synucleinopathies in Parkinson’s disease (PD)1
Practical considerations on the production of copper radioisotopes from enriched liquid targets: a five years’ experience1
PET/CT Imaging of avb6 Integrin to Monitor Radiation-Induced Pulmonary Fibrosis1
Optimal energy interval for the cyclotron production of 68Ga using solid targets1
Evaluation of 177Lu-DOTA-obinutuzumab as a new radionuclide therapeutic agent for CD20-expressing non-Hodgkin lymphoma1
Development and in vitro evaluation of a copper-64 radiolabeled antibody for targeting the CXCR4 receptor in human multiple myeloma1
Filtration of Blood for Radiometabolite Analysis in Human Subjects1
Characterization of a new Cu selective resin for the separation of Cu from Ni and Zn targets1
Evaluation of in vivo behavior of Na[F-18]F as a single substance and Na[F-18]F-contained mouthwashes via intra-trachea instillation1
Preparation of 5-[18F],7-difluoro- and 5,7-[18F]difluorotryptophans1
Metabolic profiling of mAChR ligands: In silico simulation vs LC-HRMS analysis1
Development of PSMA-targeted vectors containing an albumin binder and a cleavable linker1
Comparison of Evans Blue vs 4-(p-iodophenyl)butyric acid albumin binding moieties for lutetium-177-labeled LLP2A derivatives as theranostic agents for metastatic melanoma1
Development of noninvasive measurement for monoacylglycerol lipase activity in the brain using positron emission tomography1
A cassette-based process for the multidose production of [11C]Acetate on the AllinOne1
Chemokine receptor PET imaging: Bridging molecular insights with clinical applications1
Target manufacturing by Spark Plasma Sintering for efficient 89Zr production1
Influence of radiolysis on astatine-211 chemistry1
Large Chelators for Large Radiometals: Endeavors to Complex Radium-223 and Barium-131 to Advance Targeted Alpha Therapy and Theranostics of Cancer1
Editorial Board1
43Sc and 44Sc radiolabelling of biomolecules and their use in PET imaging1
Corrigendum to “radiation dosimetry of the 18 kDa translocator protein ligand [18F]PBR111 in humans” [nuclear medicine and biology, 144–145 (2025); 109,011]1
Modification of a commercial radiochemistry module for facile cGMP production of [18F]FET and [18F]FSPG1
Evaluation of Direct and Pretargeting Approaches for CD38 PET Imaging in NSCLC Mouse Model with Isatuximab Fragment1
Utilizing click chemistry for PET infection imaging by fluorine-18 labeling of azide-modified bacteria1
Bispidin-9-ol derivatives for copper-64:67 radiolabeling and facile biofunctionalization strategies1
Development of a CCR2 targeted 18F-labeled radiotracer for atherosclerosis imaging with PET1
Borylation and 18F-Fluorination of arenes mediated by Lewis-acid organocatalysts1
Synthesis and evaluation of an 18F-labeled PSMA-targeting tracer for imaging prostate cancer with positron emission tomography1
Preclinical evaluation of [11C]GW457427 as a tracer for neutrophil elastase1
Production of [18F]fluoromannitol facilitated by solid phase flow chemistry toward PET Imaging of bacterial Infections1
Peptide turn mimics formed by the coordination of Tc:Re-tricarbonyl1
Development of [18F]DASA-10 for enhanced imaging of pyruvate kinase M21
Imaging with Nanobody-based bimodal PET/fluorescence tracers for improved clinical decision making1
Synthesis of PET tracers for imaging of thiocyanate efflux from the brain1
New CD8 imaging agents to evaluate T-cell infiltration in tumors and predict response to immunotherapy1
Streamlined Synthesis of [18F]FSPG on the GE FASTlab™ 2 Platform for Preclinical and Clinical Applications1
CycloSiFA - Towards the Next Generation of Silicon-Fluoride Acceptor based Positron Emission Tomography (PET) Imaging Probes1
Rapid copper-mediated radiosynthesis optimization for a novel monoacylglycerol lipase PET tracer on a high-throughput microdroplet radiochemistry platform1
Copper-mediated radiofluorination: A battle against protodeboronation1
Next Generation of Radiopharmaceuticals via Engineering Antibody Derivatives1
Evaluation of 18F-Fluorosulfurylated Fluorescein Derivatives as Hybrid PET/Optical Imaging Agents1
Quantitation of a CB1R tracer [18F]FPATPP with radioLC/MS/MS1
Improving the quality of Ga radionuclides to achieve high radiolabeling yields1
8-Bicycloalkyl-CPFPX derivatives as potent and selective tools for PET imaging of the A1 adenosine receptor1
Development of Targeted Theranostics through Clinical Applicability Validation based on Pancreatic Cancer Patient-derived Organoid Platform1
Clinical translation of the GRPR antagonist [99mTc]Tc-maSSS-PEG2-RM26 for targeting prostate tumors1
Quality Control of Therapeutic Radiopharmaceuticals: Assessment of Quality Control and In Vivo Biodistribution of Radiolysed [177Lu]Lu-PSMA-I&T1
Influence of the conjugation strategy on the stability of 89Zr-labeled immunoconjugates towards radiolysis1
The Next Generation of Tumour Homing Peptides: Foldamers at the Forefront of Precise Cancer Theranostics1
Development of Astatine-211 labeling reaction using aryliodonium ylide1
Synthesis of radiopharmaceuticals (At-AITM) for melanoma with overexpressed metabotropic glutamate receptor 11
Preclinical evaluation of two new neutrophil elastase inhibitors synthesized by palladium-mediated [11C]cyanations1
Design, synthesis, and biological evaluation of orthosteric ligands for the muscarinic acetylcholine receptors1
In-vitro binding assessment of soluble and insoluble tau protein variants with [18F]-AV1451 and [18F]-MK62401
Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist1
Separation of cyclotron-produced cobalt-55/58 m from iron targets using cation exchange chromatography1
Laminated holmium-166-containing electrospun bandages for use against skin cancer1
Comparison of 89Zr-Lumi804-IAB2MA and 89Zr-DFO-IAB2MA for PSMA-targeted PET Imaging of Prostate Cancer1
Development of [64Cu]Cu-NGUL and [67Cu]Cu-NGUL as a matched-pair theranostic for prostate cancer1
Editorial Board1
Investigations of terbium-161 towards prostate cancer therapy using albumin-binding and standard PSMA ligands1
Radiosynthesis of 6-(2-cyclobutyl-5-(methyl-11C)-3H-imidazo[4,5-b]pyridin-3-yl)benzo[d]thiazol-2(3H)-one and (2-cyclobutyl-3-(1H-indazol-5-yl)-5-[11C]methyl-3H-imidazo[4,5-b]pyridine for imaging γ-8 d1
Preparation and characterization and radiolabelling of multivalent ligands towards positron emission tomography imaging of oligomeric forms of misfolded proteins involved in neurodegenerative diseases1
Synthesis and evaluation of PET ligands for monoacylglycerol lipase in brain1
Determination of sorption limit values of ion exchange resins used in the production of yttrium chloride Y-901
A facile synthesis of beta-amyloid PET imaging agent [18F]Florbetaben1
2,6-Bis-(N-hydroxylamino)-1,3,5-triazines as ligands for 45Ti-chelation1
103Ru/103mRh Auger electron emitter generator: a proof of concept1
Bioconjugates labeled with Auger electron emitter: 135La, as potential therapeutic radiopharmaceutical0
Synthesis and evaluation of novel 18F-labeled indole-based derivatives as sigma-2 receptor radioligands for imaging the proliferative status of tumors0
Synthesis of novel selective histone deacetylase inhibitors for the development of a suitable 18F-labelled radiotracer for the molecular imaging of HDAC1 in brain tumours0
Synthesis and evaluation of a [68Ga]Ga-labeled water soluble porphyrin as a tumor targeting theranostic agent: in-vitro and in-vivo studies0
Intermediates en route to [99mTc]Tc-sestamibi: insights from HPLC and HPLC-MS0
Cyclotron production of gallium-68 from liquid target: routine production of 68Ga-labelled radiotracers0
SPAAC incorporation of fluorine into FC131 analogues towards discovery of CXCR4 radiopharmaceuticals0
Optimization of the routine production of the ketone body tracer (R)-[11C]3-hydroxybutyric acid0
Synthesis and evaluation of a radioligand for PET imaging of hepsin0
Relative Biological Effectiveness (RBE) of [64Cu]Cu and [177Lu]Lu-NOTA-panitumumab F (ab')2 radioimmunotherapeutic agents vs. γ-radiation for decreasing the clonogenic survival in vitro of human pancr0
0.12460207939148